State-of-the-art lentiviral vectors for research use: risk assessment and biosafety recommendations.
par Pauwels, Katia;Gijsbers, Rik;Toelen, Jaan;Schambach, Axel;Willard-Gallo, Karen 
;Verheust, Céline;Debyser, Zeger;Herman, Philippe
Référence Current gene therapy, 9, 6, page (459-474)
Publication Publié, 2009-12
;Verheust, Céline;Debyser, Zeger;Herman, PhilippeRéférence Current gene therapy, 9, 6, page (459-474)
Publication Publié, 2009-12
Article révisé par les pairs
| Titre: |
|
| Auteur: | Pauwels, Katia; Gijsbers, Rik; Toelen, Jaan; Schambach, Axel; Willard-Gallo, Karen; Verheust, Céline; Debyser, Zeger; Herman, Philippe |
| Informations sur la publication: | Current gene therapy, 9, 6, page (459-474) |
| Statut de publication: | Publié, 2009-12 |
| Sujet CREF: | Cancérologie |
| MeSH keywords: | Animals |
| Genetic Vectors -- adverse effects | |
| Guidelines as Topic | |
| Humans | |
| Lentivirus -- genetics | |
| Risk Assessment | |
| Note générale: | Comparative Study |
| Journal Article | |
| Research Support, Non-U.S. Gov't | |
| Review | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1566-5232 |
| info:pmid/20021330 |
